PURCHASE ORDER
ActiveN0018926PB026
Department of Defense › Department of the Navy › NAVSUP FLT LOG CTR NORFOLK
$204.1K
obligated · signed 3 months ago
RESEARCH SUPPORT EXPERTISE REGARDING THE PRECLINICAL DEVELOPMENT OF CAP-DEPENDENT ENDONUCLEASE INHIBITORS (CENIS) WITH VIRUSES THAT REQUIRE BIOSAFETY LEVEL 4 (BSL-4) CONTAINMENT.
Performance timeline
Start
Jun 24, 2026
Current end
Jun 23, 2027
Potential end
Jun 23, 2029
with all options
Loading status
Estimated start: Jun 23, 2028
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Contract N0018926PB026
UEI
MSPWVMXXMN76
Parent Company
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Capabilities & Certifications
Headquarters Location
Congressional District: 14
Current Obligation
$204,095
Base + Exercised Options
$204,095
Total Ceiling Value
$794,077
Contract Type
FIRM FIXED PRICE
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Place of Performance
Congressional District: 14
Awarding Agency
Top-tier agency
Department of the Navy
Sub-tier agency
NAVSUP FLT LOG CTR NORFOLK
Office
Funding Agency
Top-tier agency
Department of the Navy
Sub-tier agency
NAVAL MEDICAL RESEARCH CENTER
Office
Solicitation procedures, competition exceptions, labor standards and account totals.